Search

Medtronic PLC

Closed

SectorHealthcare

89.44 1.03

Overview

Share price change

24h

Current

Min

88.16

Max

88.59

Key metrics

By Trading Economics

Income

206M

1.5B

Sales

-51M

9.8B

P/E

Sector Avg

22.599

55.725

EPS

1.45

Dividend yield

3.09

Profit margin

15.16

Employees

95,000

EBITDA

-682M

2B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+16.66% upside

Dividends

By Acuity

Dividend yield

Sector Avg

3.09%

2.25%

Next Earnings

17 lis 2026

Next Dividend date

16 paź 2026

Next Ex Dividend date

25 gru 2026

Market Stats

By TradingEconomics

Market Cap

1.3B

117B

Previous open

88.41

Previous close

89.44

News Sentiment

By Acuity

27%

73%

43 / 339 Ranking in Healthcare

Medtronic PLC Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

25 wrz 2026, 23:50 UTC

Medtronic PLC is down in after-market trading, continuing a seven-session trend of lower finishes and remaining significantly below its 20-day moving average.

23 wrz 2026, 20:03 UTC

News

Medtronic PLC shares fell sharply, continuing a downward trend with five consecutive losses, despite solid first-quarter results and raised full-year guidance.

22 wrz 2026, 23:21 UTC

Medtronic PLC is trading modestly higher in after-market hours, stabilizing after an initial decline amid broader market weakness.

21 wrz 2026, 19:46 UTC

News

Medtronic PLC shares fell as the company raised its adjusted profit forecast and reported revenue growth for Q1 fiscal 2027, despite FDA clearance for its LigaSure device.

18 wrz 2026, 23:06 UTC

News

Medtronic PLC raised its fiscal 2027 profit forecast and reported first-quarter revenue of $9.756 billion, exceeding expectations, in after-market trading.

17 wrz 2026, 23:06 UTC

Medtronic PLC is trading modestly higher in after-market hours, remaining near the upper end of its one-month range following Thursday's close.

16 wrz 2026, 23:01 UTC

Event

Medtronic PLC's LigaSure™ RAS Maryland jaw device received FDA clearance, but the stock is modestly lower in after-market trading since Wednesday's close.

15 wrz 2026, 23:01 UTC

Medtronic PLC shares are higher in after-market hours, tracking broader market gains. No specific company news was identified to influence this movement.

14 wrz 2026, 23:06 UTC

Medtronic PLC shares are lower in after-market hours amid a U.S. market decline linked to rising crude oil prices and supply concerns.

11 wrz 2026, 22:52 UTC

Medtronic PLC shares are lower in after-market hours, continuing recent downward momentum and trading below the 20-day moving average.

10 wrz 2026, 23:56 UTC

Medtronic PLC shares are lower in after-market hours, continuing a trend from recent sessions. Volatility marked today's trading, with no specific news identified.

9 wrz 2026, 22:02 UTC

Social Media

Medtronic PLC has been recognized by Morningstar as a top dividend stock, with shares moving higher in after-market trading since Wednesday's close.

8 wrz 2026, 23:01 UTC

Medtronic PLC shares are trading higher in after-market hours, reflecting notable fluctuations during the session and remaining near the upper end of their one-month range.

4 wrz 2026, 23:16 UTC

Shares of Medtronic PLC are higher in after-market hours, despite earlier declines. The stock remains above its 20-day moving average.

3 wrz 2026, 23:01 UTC

Medtronic PLC shares declined in after-market trading, reversing gains from earlier sessions. No specific news was identified to explain the price movement.

2 wrz 2026, 23:06 UTC

Medtronic PLC shares are trading higher in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month trading range.

1 wrz 2026, 23:06 UTC

Medtronic PLC shares declined during after-market hours, showing notable volatility. The price remains above its 20-day moving average and near the one-month range's upper end.

31 sie 2026, 23:01 UTC

Medtronic PLC shares are higher in after-market trading, positioned about 1.01% above their 20-day moving average. No specific news was identified for the movement.

29 sie 2026, 00:06 UTC

Medtronic PLC shares advanced in after-market trading, fluctuating amid broader market expectations for interest rate hikes and ongoing inflation concerns.

28 sie 2026, 23:01 UTC

Medtronic PLC shares are higher in after-market trading, with no specific news identified. The stock remains above its 20-day moving average.

27 sie 2026, 23:02 UTC

Medtronic PLC shares advanced in after-market trading, recovering from earlier volatility. Broader market context includes a decline in initial jobless claims.

26 sie 2026, 23:02 UTC

Event

Medtronic PLC shares are lower in after-market hours as investors adjust ahead of the Q1 FY2027 earnings announcement, estimating EPS at $1.39.

25 sie 2026, 23:02 UTC

Medtronic PLC shares are higher in after-market hours amid a positive market response to falling crude oil prices following U.S. sanctions against Iran.

24 sie 2026, 23:26 UTC

Medtronic PLC shares are higher in after-market trading, with no specific news identified. Broader market sentiment reflects concerns over U.S. sanctions on Iran.

22 sie 2026, 00:02 UTC

Medtronic PLC shares are lower in after-market trading, continuing a decline since Friday's close, despite broader gains in the health care equipment sector.

21 sie 2026, 23:01 UTC

Medtronic PLC shares are trading lower in after-market hours, though they remain above the 20-day moving average and near the upper end of their one-month range.

20 sie 2026, 19:56 UTC

News

Medtronic PLC shares are lower today amid broader market pressures and concerns about consumer spending following Walmart's significant decline.

19 sie 2026, 23:02 UTC

Medtronic PLC shares are lower in after-market trading, showing unusual weakness despite being above its 20-day moving average and near the upper end of its one-month range.

18 sie 2026, 23:01 UTC

Medtronic PLC shares are slightly higher in after-market hours. The stock remains above its 20-day moving average amid broader market concerns over rising Treasury yields.

17 sie 2026, 20:07 UTC

Social Media

Medtronic PLC shares are lower amid discussions of a potential AVR acquisition. Broader economic concerns include a significant drop in U.S. retail sales.

Peer Comparison

Price change

Medtronic PLC Forecast

Price Target

By TipRanks

16.66% upside

12 Months Forecast

Average 103.412 USD  16.66%

High 118 USD

Low 85 USD

Based on 20 Wall Street analysts offering 12 month price targets forMedtronic PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

20 ratings

12

Buy

8

Hold

0

Sell

Sentiment

By Acuity

43 / 339 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.